Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification and Validation of the Prognostic Impact of Metastatic Prostate Cancer Phenotypes.

Clinical genitourinary cancer - 1 Aug 2022

Labe Shelby A, Wang Xi, Lehrer Eric J, Kishan Amar U, Spratt Daniel E, Lin Christine, Morgans Alicia K, Ponsky Lee, Garcia Jorge A, Garrett Sara, Wang Ming, Zaorsky Nicholas G

Abstract excerpt

INTRODUCTION: Castration-sensitive metastatic prostate cancer is heterogeneous. Our objective is to identify metastatic prostate cancer phenotypes and their prognostic impact on survival. MATERIALS AND METHODS: The National Cancer Database was queried. The Surveillance, Epidemiology, and End Results database was used for validation. Patterns were split into: nonregional lymph node, bone only, and visceral (any...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Neoplasms
Share to Neoplasm Staging

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Nomograms

Share to Phenotype

Share to Prognosis

Share to Prostatic Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 35383004
DOI: 10.1016/j.clgc.2022.02.008
PMCID: PMC9329179

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification and Validation of the Prognostic Impact of Metastatic Prostate Cancer Phenotypes.PMID 35383004Read ↗

Clinical phenotypes of castration-resistant prostate cancer.Semantic proximity Read ↗

Determinants of widespread metastases and of metastatic tropism in patients with prostate cancer: A genomic analysis of primary and metastatic tumors.Semantic proximity Read ↗

Can We Predict Prostate Cancer Metastasis Based on Biomarkers? Where Are We Now?Semantic proximity Read ↗

Clinical and biological relevance of the transcriptomic‐based prostate cancer metastasis subtypes MetA‐CSemantic proximity Read ↗

Integration of genomic classification and clinical characteristics predicts survival in metastatic prostate cancerSemantic proximity Read ↗

Gene expression profiles define molecular subtypes of prostate cancer bone metastases with different outcomes and morphology traceable back to the primary tumorSemantic proximity Read ↗

De Novo Metastatic Prostate Cancer: Are We Moving toward a Personalized Treatment?Semantic proximity Read ↗

Metastatic prostate cancer is associated with distinct higher frequency of genetic mutations at diagnosis.Semantic proximity Read ↗

Prediction of Metastatic Site Based On Somatic Gene Mutations in Primary Tumors in Prostate CancerSemantic proximity Read ↗

The Genomic Landscape of Prostate Cancer Brain MetastasesSemantic proximity Read ↗

Prevalence and clinical impact of tumor BRCA1 and BRCA2 mutations in patients presenting with localized or metastatic hormone-sensitive prostate cancer.Semantic proximity Read ↗

De Novo Metastatic Prostate Cancer: Are We Moving towards a Personalized Treatment?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.